Literature DB >> 12710596

Acute renal toxic effect of amiodarone in rats.

Ana Isabel Morales1, Jose Diogo Barata, Margarida Bruges, Miguel Angel Arévalo, José Manuel González de Buitrago, Patricia Palma, Patricia Branco, Fernando Pérez-Barriocanal.   

Abstract

Amiodarone is an antiarrhythmic drug now more frequently used after a number of years in which the use had been on the decline due to a number of studies which reported side effects such as chronic toxicity, primarily in the lungs, liver and thyroid glands. Additionally, in some patients an increase in serum creatinine was noted, however the effect of amiodarone on renal function had never been closely examined. Thus, the aim of our study was to analyse the effects of amiodarone on renal function in rats. Experiments were carried out in male Wistar rats divided in two experimental groups: 1) a control group, (n=8), 2) a group that received a daily intraperitoneal injection of amiodarone (50 mg/kg body weight) for 6 days (n=5). At the end of the treatment, renal function was measured by clearance creatinine and acute clearance studies. Renal toxicity was evaluated by urinary N-acetyl-glucosamine and alkaline phosphatase. At the end of the experiment, histology studies were done. Rats treated with amiodarone had a higher serum creatinine (182%) and a lower glomerular filtration rate (53%), renal plasma flow (68%) and filtration fraction (62%) than controls. Rats treated with amiodarone also showed an increase in urinary N-acetyl-glucosamine (221%) and alkaline phosphatase (4.151%) excretion which corresponds with tubular alterations showed on electron microscopy. In conclusion our data confirm that amiodarone induces acute renal damage in the rat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710596     DOI: 10.1034/j.1600-0773.2003.920107.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  4 in total

1.  Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Wesley T O'Neal; Rikki M Tanner; Jimmy T Efird; Usman Baber; Alvaro Alonso; Virginia J Howard; George Howard; Paul Muntner; Elsayed Z Soliman
Journal:  Int J Cardiol       Date:  2015-03-12       Impact factor: 4.164

2.  Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis.

Authors:  James F Doyle; Kwok M Ho
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

3.  Interactions between thyroid disorders and kidney disease.

Authors:  Gopal Basu; Anjali Mohapatra
Journal:  Indian J Endocrinol Metab       Date:  2012-03

4.  Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy.

Authors:  Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska; Longin Niemczyk; Robert Wrzesien; Marzanna Tkaczyk; Liana Puchalska; Marek Saracyn; Wawrzyniec Zmudzki; Stanisław Niemczyk
Journal:  Biomed Res Int       Date:  2018-06-14       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.